These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38827740)

  • 41. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients.
    Luzina IG; Atamas SP; Wise R; Wigley FM; Choi J; Xiao HQ; White B
    Arthritis Rheum; 2003 Aug; 48(8):2262-74. PubMed ID: 12905481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2.
    Zheng HY; He XY; Li W; Song TZ; Han JB; Yang X; Liu FL; Luo RH; Tian RR; Feng XL; Ma YH; Liu C; Li MH; Zheng YT
    Signal Transduct Target Ther; 2021 Sep; 6(1):328. PubMed ID: 34471088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative analysis of TCR immune repertoire in COVID-19 patients.
    Zhu X; Ma E; Ning K; Feng X; Quan W; Wang F; Zhu C; Ma Y; Dong Y; Jiang Q
    Hum Immunol; 2024 May; 85(3):110795. PubMed ID: 38582657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4
    Servaas NH; Zaaraoui-Boutahar F; Wichers CGK; Ottria A; Chouri E; Affandi AJ; Silva-Cardoso S; van der Kroef M; Carvalheiro T; van Wijk F; Radstake TRDJ; Andeweg AC; Pandit A
    J Autoimmun; 2021 Feb; 117():102574. PubMed ID: 33307312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine.
    Sureshchandra S; Lewis SA; Doratt BM; Jankeel A; Coimbra Ibraim I; Messaoudi I
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34935643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated single-cell transcriptome and T cell receptor profiling reveals defects of T cell exhaustion in pulmonary tuberculosis.
    Wen Z; Wang L; Ma H; Li L; Wan L; Shi L; Li H; Chen H; Hao W; Song S; Xue Q; Wei Y; Li F; Xu J; Zhang S; Wong KW; Song Y
    J Infect; 2024 Jun; 88(6):106158. PubMed ID: 38642678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'.
    Fischer DS; Ansari M; Wagner KI; Jarosch S; Huang Y; Mayr CH; Strunz M; Lang NJ; D'Ippolito E; Hammel M; Mateyka L; Weber S; Wolff LS; Witter K; Fernandez IE; Leuschner G; Milger K; Frankenberger M; Nowak L; Heinig-Menhard K; Koch I; Stoleriu MG; Hilgendorff A; Behr J; Pichlmair A; Schubert B; Theis FJ; Busch DH; Schiller HB; Schober K
    Nat Commun; 2021 Jul; 12(1):4515. PubMed ID: 34312385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-Related Dynamics of Lung-Resident Memory CD8
    Goplen NP; Cheon IS; Sun J
    Front Immunol; 2021; 12():636118. PubMed ID: 33854506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8
    Kusnadi A; Ramírez-Suástegui C; Fajardo V; Chee SJ; Meckiff BJ; Simon H; Pelosi E; Seumois G; Ay F; Vijayanand P; Ottensmeier CH
    Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33478949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19.
    Cooper RS; Fraser AR; Smith L; Burgoyne P; Imlach SN; Jarvis LM; Turner DM; Zahra S; Turner ML; Campbell JDM
    Front Immunol; 2020; 11():598402. PubMed ID: 33488592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD8
    Lineburg KE; Grant EJ; Swaminathan S; Chatzileontiadou DSM; Szeto C; Sloane H; Panikkar A; Raju J; Crooks P; Rehan S; Nguyen AT; Lekieffre L; Neller MA; Tong ZWM; Jayasinghe D; Chew KY; Lobos CA; Halim H; Burrows JM; Riboldi-Tunnicliffe A; Chen W; D'Orsogna L; Khanna R; Short KR; Smith C; Gras S
    Immunity; 2021 May; 54(5):1055-1065.e5. PubMed ID: 33945786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
    Kared H; Redd AD; Bloch EM; Bonny TS; Sumatoh H; Kairi F; Carbajo D; Abel B; Newell EW; Bettinotti MP; Benner SE; Patel EU; Littlefield K; Laeyendecker O; Shoham S; Sullivan D; Casadevall A; Pekosz A; Nardin A; Fehlings M; Tobian AA; Quinn TC
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33427749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.
    Jung MK; Shin EC
    Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients.
    Zhao XN; You Y; Cui XM; Gao HX; Wang GL; Zhang SB; Yao L; Duan LJ; Zhu KL; Wang YL; Li L; Lu JH; Wang HB; Fan JF; Zheng HW; Dai EH; Tian LY; Ma MJ
    Signal Transduct Target Ther; 2021 Sep; 6(1):342. PubMed ID: 34531370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype.
    Guerrera G; Picozza M; D'Orso S; Placido R; Pirronello M; Verdiani A; Termine A; Fabrizio C; Giannessi F; Sambucci M; Balice MP; Caltagirone C; Salvia A; Rossini A; Battistini L; Borsellino G
    Sci Immunol; 2021 Dec; 6(66):eabl5344. PubMed ID: 34726470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human CD4
    Verhagen J; van der Meijden ED; Lang V; Kremer AE; Völkl S; Mackensen A; Aigner M; Kremer AN
    Clin Exp Immunol; 2021 Sep; 205(3):363-378. PubMed ID: 34061349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suboptimal SARS-CoV-2-specific CD8
    Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IFN-γ
    Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
    Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.